Risk factors for kidney damage in the adult population of Wadena, Minnesota: A prospective study

American Journal of Epidemiology

Volumn 145, Issue 2, 1997, Pages 91-102

  Goetz, Frederick C ^a,b   Jacobs Jr , David R ^b   Chavers, Blanche ^a   Roel, Joseph ^b   Yelle, Matthew ^c   Michael Sprafka, J ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Wadena Medical Center   (United States)

Author keywords

albuminuria; Caucasoid race; creatinine clearance; diabetes mellitus, insulin dependent; diabetes mellitus, non insulin dependent; glucose intolerance; glycosuria; kidney

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CIGARETTE SMOKING; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; ETHNIC GROUP; FEMALE; GLUCOSE INTOLERANCE; GLUCOSURIA; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; PROTEINURIA; RACE DIFFERENCE; RISK FACTOR; UNITED STATES;

DIABETES MELLITUS; KIDNEY DAMAGE; RISK FACTOR;

USA;

EID: 0030609490     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009091     Document Type: Article

References (83)

1. Keen H, Chlouverakis C, Fuller J, et al. The concomitants of raised blood sugar: studies in newly-detected hyperglycaemics. II. Urinary albumin excretion, blood pressure and their relation to blood sugar levels. Guys Hosp Rep 1969;118:247-54.
2. Viberti GC, Hill RD, Jarrett RJ, et al. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982;1:1430-2.
3. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984;311:89-93.
4. Chavers BM, Bilous RW, Ellis EN, et al. Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. N Engl J Med 1989;320:966-70.
5. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects: Islington Diabetes Survey. Lancet 1988;2:530-3.
6. Haffner SM, Stern MP, Gruber MK, et al. Microalbuminuria: potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 1990;10:727-31.
7. Parving HH, Mogensen CE, Jensen HA, et al. Increased urinary albumin-excretion rate in benign essential hypertension. Lancet 1974;1:1190-2.
8. Ledingham JG. Early assessment of organ involvement in hypertension: renal assessment. J Hypertens 1985;3(suppl 2):S33-5.
9. Scarpelli PT, Chegai E, Castigli E, et al. Renal handling of albumin and beta-2-microglobulin in human hypertension. (Letter). Nephron 1985;40:122-3.
10. Losito A, Fortunati F, Zampi I, et al. Impaired renal functional reserve and albuminuria in essential hypertension. Br Med J 1988;296:1562-4.
11. Mogensen CE, Hansen KW, Østerby R, et al. Blood pressure elevation versus abnormal albuminuria in the genesis and prediction of renal disease in diabetes. Diabetes Care 1992;15:1192-204.
12. Mathiesen ER, Rønn B, Jensen T, et al. Relationship between blood pressure and urinary albumin excretion in development of microalbuminuria. Diabetes 1990;39:245-9.
13. Winocour PH, Harland JO, Millar JP, et al. Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis 1992;93:71-81.
14. Borch-Johnsen K, Andersen PK, Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1985;28:590-6.
15. Valdorf-Hansen F, Jensen T, Borch-Johnsen K, et al. Cardiovascular risk factors in type 1 (insulin-dependent) diabetic patients with and without proteinuria. Acta Med Scand 1987;222:439-44.
16. Microalbuminuria Collaborative Study Group, United Kingdom. Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. BMJ 1993;306:1235-9.
17. Alzaid AA. Microalbuminuria in patients with NIDDM: an overview. Diabetes Care 1996;19:79-89.
18. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984;310:356-60.
19. Schmitz A. Renal function changes in middle-aged and elderly Caucasian type 2 (non-insulin-dependent) diabetic patients - a review. Diabetologia 1993;36:985-92.
20. Nelson RG, Kunzelman CL, Pettit DJ, et al. Albuminuria in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians. Diabetologia 1989;32:870-6.
21. Collins VR, Dowse GK, Finch CF, et al. Prevalence and risk factors for micro- and macroalbuminuria in diabetic subjects and entire population of Nauru. Diabetes 1989;38:1602-10.
22. Klein R, Klein BE, Moss SE. Incidence of gross proteinuria in older-onset diabetes: a population-based perspective. Diabetes 1993;42:381-9.
23. Bender AP, Sprafka JM, Jagger H, et al. Incidence, prevalence, mortality and population-based profile of diabetes mellitus in Wadena, Minnesota - 1981. Minn Med 1983;66:251-6.
24. French LR, Boen JR, Martinez AM, et al. Population-based study of impaired glucose tolerance and type II diabetes in Wadena, Minnesota. Diabetes 1990;39:1131-7.
25. Bushhouse SA, Goetz FC, Jacobs DR Jr, et al. C-peptide response to meal challenge in nondiabetic and diabetic adults living in Wadena, Minnesota. Diabetes Care 1992;15:1335-47.
26. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
27. World Health Organization. WHO Expert Committee on Diabetes Mellitus: second report. WHO Tech Rep Ser 1980;646:1-80.
28. Collins AC, Sethi M, MacDonald FA, et al. Storage temperature and differing methods of sample preparation in the measurement of urinary albumin. Diabetologia 1993;36:993-7.
29. Chavers BM, Simonson J, Michael AF. A solid phase fluorescent immunoassay for the measurement of human urinary albumin. Kidney Int 1984;25:576-8.
30. Chavers BM, Mauer SM, Ramsay RC, et al. Relationship between retinal and glomerular lesions in IDDM patients. Diabetes 1994;43:441-6.
31. Mogensen CE, Chachati A, Christensen CK, et al. Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 1986;9:85-95.
32. Bennett PH, Haffner S, Kasiske BL, et al. Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the scientific advisory board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kidney Dis 1995;25:107-12.
33. Jaffe M. Über den Niederschlag welchen Pikrinsäure in normale Ham erzeugt, und über eine neue Reaction des Kreati nins. (In German). Z Physiol Chem 1886;10:391-400.
34. Schmilz A, Vaeth M. Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabet Med 1988;5:126-34.
35. Damsgaard EM, Frøland A, Jørgensen OD, et al. Prognostic value of urinary albumin excretion rate and other risk factors in elderly diabetic patients and non-diabetic control subjects surviving the first 5 years after assessment. Diabetologia 1993;36:1030-6.
36. Gall M-A, Rossing P, Skøtt P, et al. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients, Diabetologia 1991;34:655-61.
37. Olivarius N, Andreasen AH, Keiding N, et al. Epidemiology of renal involvement in newly diagnosed middle-aged and elderly diabetic patients: cross-sectional data from the population-based study "Diabetes Care in General Practice", Denmark. Diabetologia 1993;36:1007-16.
38. Standl E, Stiegler H. Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin-dependent) diabetic patients living in the Greater Munich area. Diabetologia 1993;36:1017-20.
39. Uusitupa M, Siitonen O, Penttilä I, et al. Proteinuria in newly diagnosed type II diabetic patients. Diabetes Care 1987;10:191-4.
40. Gatling W, Knight C, Mullee MA, et al. Microalbuminuria in diabetes: a population study of the prevalence and an assessment of three screening tests. Diabet Med 1988;5:343-7.
41. Neil A, Hawkins M, Potok M, et al. A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 1993;16:996-1003.
42. Mattock MB, Morrish NJ, Viberti G, et al. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992;41:736-41.
43. Patrick AW, Leslie PJ, Clarke BF, et al. The natural history and associations of microalbuminuria in type 2 diabetes during the first year after diagnosis. Diabet Med 1990;7:902-08.
44. Jerums G, Cooper ME, Seeman E, et al. Comparison of early renal dysfunction in type I and type II diabetes: differing associations with blood pressure and glycaemic control. Diabetes Res Clin Pract 1988;4:133-41.
45. Metcalf PA, Baker JR, Scragg RK, et al. Microalbuminuria in a middle-aged workforce: effect of hyperglycemia and ethnicity. Diabetes Care 1993;16:1485-93.
46. Klein R, Klein BE, Moss SE. Prevalence of microalbuminuria in older-onset diabetes. Diabetes Care 1993;16:1325-30.
47. Jiang X, Srinivasan SR, Radhakrishnamurthy B, et al. Microalbuminuria in young adults related to blood pressure in a biracial (black-white) population: The Bogalusa Heart Study. Am J Hypertens 1994;7:794-800.
48. Vestbo E, Damsgaard EM, Frøland A, et al. Urinary albumin excretion in a population based cohort. Diabet Med 1995;12:488-93.
49. Haffner SM, Gonzales C, Valdez RA, et al. Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study. Diabetologia 1993;36:1002-6.
50. Pan X-R, Hu Y-H, Li G-W, et al. Impaired glucose tolerance and its relationship to ECG-indicated coronary heart disease and risk factors among Chinese: Da Qing IGT and Diabetes Study. Diabetes Care 1993;16:150-56.
51. Mykkänen L, Haffner SM, Kuusisto J, et al. Microalbuminuria precedes the development of NIDDM. Diabetes 1994;43:552-7.
52. Allawi J, Rao PV, Gilbert R, et al Microalbuminuria in non-insulin-dependent diabetes: its prevalence in Indian compared with Europid patients. Br Med J 1988;296:462-4.
53. Haffner SM, Mitchell BD, Pugh JA, et al. Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM. Diabetes Care 1989;12:530-6.
54. Hamman RF, Franklin GA, Mayer EJ. Microvascular complications of NIDDM in Hispanics and non-Hispanic whites: San Luis Valley Diabetes Study. Diabetes Care 1991;14:655-64.
55. Mather HM, Keen H. The Southall Diabetes Survey: prevalence of known diabetes in Asians and Europeans. Br Med J 1985;291:1081-4.
56. Sievers ML, Nelson RG, Knowler WC, et al. Impact of NIDDM on mortality and causes of death in Pima Indians. Diabetes Care 1992;15:1541-9.
57. Brancati FL, Whittle JC, Whelton PK, et al. The excess incidence of diabetic end-stage renal disease among blacks: a population-based study of potential explanatory factors. JAMA 1992;268:3079-84.
58. Simmons D, Shaw LM, Scott DJ, et al. Diabetic nephropathy and microalbuminuria in the community: The South Auckland Diabetes Survey. Diabetes Care 1994;117:1404-10.
59. Seaquist ER, Goetz FC, Rich S, et al. Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989;320:1161-5.
60. Luft FC, Fineberg NS, Miller JZ, et al. The effects of age, race and heredity on glomerular filtration rate following volume expansion and contraction in normal man. Am J Med Sci 1980;279:15-24.
61. James GD, Sealey JE, Alderman M, et al. A longitudinal study of urinary creatinine and creatinine clearance in normal subjects: race, sex, and age differences. Am J Hypertens 1988;1:124-31.
62. Danziger RS, Tobin JD, Becker LC, et al. The age-associated decline in glomerular filtration in healthy normotensive volunteers: lack of relationship to cardiovascular performance. J Am Geriatr Soc 1990;38:1127-32.
63. Malmrose LC, Gray SL, Pieper CF, et al. Measured versus estimated creatinine clearance in a high-functioning elderly sample: MacArthur Foundation Study of Successful Aging. J Am Geriatr Soc 1993;41:715-21.
64. Sokoll LJ, Russell RM, Sadowski JA, et al. Establishment of creatinine clearance reference values for older women. Clin Chem 1994;40:2276-81.
65. Davies DF, Shock NW. Age changes in glomerular filtration rate, effective renal plasma flow and tubular excretory capacity in adult males. J Clin Invest 1950;29:496-507.
66. Rowe JW, Andres R, Tobin JD, et al. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol 1976;31:55-63.
67. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982;307:652-9.
68. National Heart, Lung, and Blood Institute. The Lipid Research Clinics population studies data book. Vol 2. The prevalence study - nutrient intake. Bethesda, MD: National Institutes of Health, 1982:38-9. (NIH publication no. 82-2014).
69. Brunner FP, Brynger H, Challah S, et al. Renal replacement therapy in patients with diabetic nephropathy, 1980-1985: report from the European Dialysis and Transplant Association Registry. Nephrol Dial Transplant 1988;3:585-95.
70. Carpenter A-M, Goetz FC, LeCompte PM, et al. Glomerulosclerosis in type 2 (non-insulin-dependent) diabetes mellitus: relationship to glycaemia in the University Group Diabetes Program (UGDP). Diabetologia 1993;36:1057-63.
71. Sharp CL, Butterfield WJ, Keen H. Diabetes survey in Bedford 1962. Proc R Soc Med 1964;57:193-202.
72. Christiansen JS. Cigarette smoking and prevalence of microangiopathy in juvenile-onset insulin-dependent diabetes mellitus. Diabetes Care 1978;1:146-9.
73. Telmer S, Christiansen JS, Andersen AR, et al. Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics. Acta Med Scand 1984;215:63-8.
74. Norden G, Nyberg G. Smoking and diabetic nephropathy. Acta Med Scand 1984;215:257-61.
75. Mühlhauser I. Cigarette smoking and diabetes: an update. Diabet Med 1994;11:336-43.
76. Ekberg G, Grefberg N, Larsson L-O, et al. Cigarette smoking and glomerular filtration rate in insulin-treated diabetics without manifest nephropathy. J Intern Med 1990;228:211-17.
77. Sawicki PT, Didjurgeit U, Mühlhauser I, et al. Smoking is associated with progression of diabetic nephropathy. Diabetes Care 1994;17:126-31.
78. Myers BD, Nelson RG, Williams GW, et al. Glomerular function in Pima Indians with non-insulin-dependent diabetes mellitus of recent onset. J Clin Invest 1991;88:524-30.
79. van den Born J, van Kraats AA, Bakker MA, et al. Reduction of heparan sulphate-associated anionic sites in the glomerular basement membrane of rats with streptozotocin-induced diabetic nephropathy. Diabetologia 1995;38:1169-75.
80. Daniels BS, Hauser EB. Glycation of albumin, not glomerular basement membrane, alters permeability in an in vitro model. Diabetes 1992;41:1415-21.
81. Hostetter TH. Mechanisms of diabetic nephropathy. Am J Kidney Dis 1994;23:188-92.
82. Rosenberg ME, Hostetter TH. Comparative effects of antihypertensives on proteinuria: angiotensin-converting enzyme inhibitor versus alpha 1-antagonist. Am J Kidney Dis 1991;18:472-82.
83. Viberti GC, Mackintosh D, Bilous RW, et al. Proteinuria in diabetes mellitus: role of spontaneous and experimental variation of glycemia. Kidney Int 1982;21:714-20.